Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 646794, 8 pages
http://dx.doi.org/10.1155/2012/646794
Research Article

Prevalence of Metabolic Syndrome according to Sasang Constitutional Medicine in Korean Subjects

Division of Constitutional Medicine Research, Korea Institute of Oriental Medicine, 483 Expo-ro, Yuseong-gu, Daejeon 305-811, Republic of Korea

Received 10 August 2011; Accepted 29 October 2011

Academic Editor: Carlo Ventura

Copyright © 2012 Kwang Hoon Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Institute of Health, Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III), National Institute of Health, Bethesda, Md, USA, 2001.
  2. G. M. Reaven, “Banting Lecture 1988. Role of insulin resistance in human disease,” Diabetes, vol. 37, pp. 1595–1607, 1988. View at Google Scholar
  3. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Grundy, H. B. Brewer, J. I. Cleeman, S. C. Smith, and C. Lenfant, “Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 2, pp. e13–18, 2004. View at Google Scholar · View at Scopus
  5. E. S. Ford, W. H. Giles, and W. H. Dietz, “Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey,” Journal of the American Medical Association, vol. 287, no. 3, pp. 356–359, 2002. View at Google Scholar · View at Scopus
  6. S. M. Grundy, H. B. Brewer, J. I. Cleeman, S. C. Smith, and C. Lenfant, “Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition,” Circulation, vol. 109, no. 3, pp. 433–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. S. Ford, “Prevalence of the metabolic syndrome in US populations,” Endocrinology and Metabolism Clinics of North America, vol. 33, no. 2, pp. 333–350, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Meigs, P. W. F. Wilson, D. M. Nathan, R. B. D'Agostino, K. Williams, and S. M. Haffner, “Prevalence and characteristics of the metabolic syndrome in the San Antonio heart and Framingham Offspring studies,” Diabetes, vol. 52, no. 8, pp. 2160–2167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Lee, Dong-Yi-Soo-Se-Bo-Won, Je Ma Lee, Seoul, Republic of Korea, 1894.
  10. J. Y. Kim and D. D. Pham, “Sasang constitutional medicine as a holistic tailored medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 6, supplement 1, pp. 11–19, 2009. View at Publisher · View at Google Scholar
  11. E. B. Shim, S. Lee, J. Y. Kim, and Y. E. Earm, “Physiome and sasang constitutional medicine,” Journal of Physiological Sciences, vol. 58, no. 7, pp. 433–440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. G. Lee, B. Koh, and S. Lee, “Sasang constitution as a risk factor for diabetes mellitus: a cross-sectional study,” Evidence-Based Complementary and Alternative Medicine, vol. 6, supplement 1, pp. 99–103, 2009. View at Publisher · View at Google Scholar
  13. J. Lee, Y. Jung, J. Yoo, E. Lee, and B. Koh, “Perspective of the human body in sasang constitutional medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 6, supplement 1, pp. 31–41, 2009. View at Publisher · View at Google Scholar
  14. J. Y. Kim, K. H. Song, S. -G. Yu, and S. Cha, “Association of the apolipoprotein A5 gene -1131t>c polymorphism with serum lipids in Korean subjects: impact of Sasang constitution,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 598394, 2012. View at Publisher · View at Google Scholar
  15. “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 29, supplement 1, pp. S43–S48, 2006.
  16. WHO, IASO, and IOTF, “The asia-pacific perspective: redefining obesity and its treatment,” Health Communications Australia, Melbourne, Australia, 2000. View at Google Scholar
  17. S. Lim, H. Shin, J. H. Song et al., “Increasing prevalence of metabolic syndrome in Korea: the Korean national health and nutrition examination survey for 1998–2007,” Diabetes Care, vol. 34, no. 6, pp. 1323–1328, 2011. View at Publisher · View at Google Scholar
  18. R. Villegas, I. J. Perry, D. Creagh, R. Hinchion, and D. O'Halloran, “Prevalence of the metabolic syndrome in middle-aged men and women,” Diabetes Care, vol. 26, no. 11, pp. 3198–3199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. H. M. Kim, J. Park, S. Y. Ryu, and J. Kim, “The effect of menopause on the metabolic syndrome among Korean women: the Korean national health and nutrition examination survey, 2001,” Diabetes Care, vol. 30, no. 3, pp. 701–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnethon, and S. B. Heymsfield, “The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994,” Archives of Internal Medicine, vol. 163, no. 4, pp. 427–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Choi, J. Lee, J. Yoo, E. Lee, and B. Koh, “Sasang constitutional types can act as a risk factor for insulin resistance,” Diabetes Research and Clinical Practice, vol. 91, pp. e57–60, 2011. View at Publisher · View at Google Scholar · View at Scopus